Risk of myocardial infarction in patients with atrial fibrillation using vitamin K antagonists, aspirin or direct acting oral anticoagulants (vol 83, pg 1835, 2017) - correction

L. M. Stolk; F. de Vries; C. Ebbelaar; Anthonius de Boer; Tom Schalekamp; Patrick Souverein; Arina Hoek - ten Cate; Andrea Burden

doi:10.1111/bcp.14001

Risk of myocardial infarction in patients with atrial fibrillation using vitamin K antagonists, aspirin or direct acting oral anticoagulants (vol 83, pg 1835, 2017) - correction

L. M. Stolk
, F. de Vries
, C. Ebbelaar
, Anthonius de Boer
, Tom Schalekamp
, Patrick Souverein
, Arina Hoek - ten Cate
, Andrea Burden

Research output: Contribution to journal › Erratum / corrigendum › Academic

Original language	English
Pages (from-to)	1864-1864
Number of pages	1
Journal	British Journal of Clinical Pharmacology
Volume	85
Issue number	8
DOIs	https://doi.org/10.1111/bcp.14001
Publication status	Published - Aug 2019

Access to Document

10.1111/bcp.14001

1 Article

Risk of myocardial infarction in patients with atrial fibrillation using vitamin K antagonists, aspirin or direct acting oral anticoagulants
Stolk, L. M., de Vries, F., Ebbelaar, C., de Boer, A., Schalekamp, T., Souverein, P., ten Cate-Hoek, A. & Burden, A. M., Aug 2017, In: British Journal of Clinical Pharmacology. 83, 8, p. 1835-1843 9 p.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access
File
99 Downloads (Pure)

Cite this

Stolk, L. M., de Vries, F., Ebbelaar, C., de Boer, A., Schalekamp, T., Souverein, P., Hoek - ten Cate, A., & Burden, A. (2019). Risk of myocardial infarction in patients with atrial fibrillation using vitamin K antagonists, aspirin or direct acting oral anticoagulants (vol 83, pg 1835, 2017) - correction. British Journal of Clinical Pharmacology, 85(8), 1864-1864. https://doi.org/10.1111/bcp.14001

@article{bb264f062d41484caf8239d87471069d,

title = "Risk of myocardial infarction in patients with atrial fibrillation using vitamin K antagonists, aspirin or direct acting oral anticoagulants (vol 83, pg 1835, 2017) - correction",

author = "Stolk, \{L. M.\} and \{de Vries\}, F. and C. Ebbelaar and \{de Boer\}, Anthonius and Tom Schalekamp and Patrick Souverein and \{Hoek - ten Cate\}, Arina and Andrea Burden",

year = "2019",

month = aug,

doi = "10.1111/bcp.14001",

language = "English",

volume = "85",

pages = "1864--1864",

journal = "British Journal of Clinical Pharmacology",

issn = "0306-5251",

publisher = "Wiley-Blackwell",

number = "8",

}

Stolk, LM, de Vries, F, Ebbelaar, C, de Boer, A, Schalekamp, T, Souverein, P, Hoek - ten Cate, A & Burden, A 2019, 'Risk of myocardial infarction in patients with atrial fibrillation using vitamin K antagonists, aspirin or direct acting oral anticoagulants (vol 83, pg 1835, 2017) - correction', British Journal of Clinical Pharmacology, vol. 85, no. 8, pp. 1864-1864. https://doi.org/10.1111/bcp.14001

Risk of myocardial infarction in patients with atrial fibrillation using vitamin K antagonists, aspirin or direct acting oral anticoagulants (vol 83, pg 1835, 2017) - correction. / Stolk, L. M.; de Vries, F.; Ebbelaar, C. et al.
In: British Journal of Clinical Pharmacology, Vol. 85, No. 8, 08.2019, p. 1864-1864.

Research output: Contribution to journal › Erratum / corrigendum › Academic

TY - JOUR

T1 - Risk of myocardial infarction in patients with atrial fibrillation using vitamin K antagonists, aspirin or direct acting oral anticoagulants (vol 83, pg 1835, 2017) - correction

AU - Stolk, L. M.

AU - de Vries, F.

AU - Ebbelaar, C.

AU - de Boer, Anthonius

AU - Schalekamp, Tom

AU - Souverein, Patrick

AU - Hoek - ten Cate, Arina

AU - Burden, Andrea

PY - 2019/8

Y1 - 2019/8

U2 - 10.1111/bcp.14001

DO - 10.1111/bcp.14001

M3 - Erratum / corrigendum

C2 - 31297854

SN - 0306-5251

VL - 85

SP - 1864

EP - 1864

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

IS - 8

ER -